JPIAMR is a global collaborative platform, engaging 28 member nations to curb antibiotic resistance (AMR) with a One Health approach. The initiative coordinates national funding to support transnational research and activities within the six priority areas of the shared JPIAMR Strategic Research and Innovation Agenda – therapeutics, diagnostics, surveillance, transmission, environment and interventions.
To date JPIAMR has supported 61 projects and over 340 research groups, 38 networks, with funding of approximately 80 million Euro. G7, G20 and the EU recognizes JPIAMR as a key initiative to support and as a mechanism enabling global collaboration and coordination of calls. JPIAMR is continuously adding member nations.
The JPIAMR is currently developing a platform to extend shared research capabilities on a global scale through the Virtual Research Institute (JPIAMR-VRI).
JPIAMR is mapping AMR research funding continuously. 1,8 billion € has been invested by Jan. 1st, 2017, in AMR research by JPIAMR members. JPIAMR has created an interactive dashboard that provides overview of the grant investments and research capacities. This tool visualises key data on how to invest in AMR research. Avoiding duplication – enabling innovation. Explore the AMR Research Funding Dashboard.
The Secretariat of JPIAMR is hosted by the Swedish Research Council in Stockholm, Sweden.